Psychiatry
Partner With Us
Advertisement
Conexiant chevron_right Psychiatry chevron_right FDA & Government News

FDA & Government News

thumb description

July 27, 2026

FDA Approves Centanafadine for ADHD

The first approved norepinephrine, dopamine, and serotonin reuptake inhibitor for ADHD demonstrated symptom improvements as early as week 1 in phase 3 trials.

Conexiant

thumb description

July 17, 2026

ADHD Stimulant Misuse Under Review

High-frequency misuse remains associated with polysubstance use, while no studies evaluated long-term physical health outcomes.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

July 10, 2026

10 CMS and FDA Actions Affecting Care in 2026

From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.

Conexiant

thumb description

July 09, 2026

Top 10 CDC Updates Physicians Should Know

Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.

Conexiant

thumb description

July 07, 2026

Settlement Bars Two From DEA Registration

A DOJ settlement resolved allegations involving a cash-pay pain practice in which continued access to controlled-substance prescriptions was tied to recurring payments.

Conexiant